Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

NCT01868646 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT01868646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01868646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus
Lead sponsor
Materia Medica Holding
Phase
Phase 4
Overall status
Completed
Start date
May 7, 2013
Completion date
June 15, 2016
Enrollment
190 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus